FDARxBench: Benchmarking Regulatory and Clinical Reasoning on FDA Generic Drug Assessment

📰 ArXiv cs.AI

FDARxBench is a benchmark for evaluating document-grounded question-answering in generic drug assessment using FDA drug label documents

advanced Published 23 Mar 2026
Action Steps
  1. Curate a dataset of FDA drug label documents
  2. Develop a benchmark to evaluate document-grounded question-answering models
  3. Collaborate with regulatory assessors to ensure the benchmark is relevant and effective
  4. Use FDARxBench to evaluate and improve the performance of language models in regulatory and clinical reasoning
Who Needs to Know This

Data scientists and AI engineers on a team can benefit from FDARxBench to evaluate and improve the performance of language models in regulatory and clinical reasoning, while regulatory assessors can use it to develop more accurate question-answering systems

Key Insight

💡 FDARxBench provides a real-world benchmark for evaluating the performance of language models in regulatory and clinical reasoning

Share This
📊 Introducing FDARxBench: a benchmark for evaluating document-grounded QA in generic drug assessment
Read full paper → ← Back to News